Human patients with a loss of functional ATGL suffer from a neutral lipid storage disease characterized by abnormal TG accumulation in multiple organs and tissues, leading to cardiac and skeletal muscle myopathy. Here, PNPLA2 is linked to glycogen storage disease VI.